Result of AGM
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
New York, Belfast and London, 18 June 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, is pleased to announce that all resolutions proposed at its Annual General Meeting held earlier today, were duly passed. The proxy votes received from shareholders in respect of each resolution are set out below and are available on the Company's website www.diaceutics.com
| Resolution | For (excluding at Chair's discretion) | Against | Total votes cast | Withheld | |||
|---|---|---|---|---|---|---|---|
| Number of votes | % | Number of votes | % | Number of votes | Number of votes | ||
| 1 | Ordinary resolution to receive To receive and consider the Company's financial statements for the financial year ended 31 December 2024 together with the directors' report and the auditors' report on those annual accounts | 54,937,420 | 99.99% | 577 | 0.01% | 54,937,997 | Nil |
| 2 | Ordinary resolution to approve the directors' remuneration report | 44,895,272 | 83.09% | 9,136,725 | 16.91% | 54,937,997 | 906,000 |
| 3 | Ordinary resolution to re-elect Cheryl MacDiarmid as a director of the Company | 54,937,420 | 99.99% | 577 | 0.01% | 54,937,997 | Nil |
| 4 | Ordinary resolution to re-elect Jordan Clark as a director of the Company | 51,811,362 | 99.98% | 11,300 | 0.02% | 54,937,997 | 3,115,335 |
| 5 | Ordinary resolution to re-elect Nick Roberts as a director of the Company | 51,639,642 | 99.65% | 183,020 | 0.35% | 54,937,997 | 3,115,335 |
| 6 | Ordinary resolution to re-appoint Ernst & Young as auditors of the Company | 54,925,512 | 99.98% | 12,485 | 0.02% | 54,937,997 | Nil |
| 7 | Ordinary resolution to authorise the directors to determine the remuneration of the auditors | 54,937,420 | 99.99% | 577 | 0.01% | 54,937,997 | Nil |
| 8 | Ordinary resolution to authorise the directors to allot ordinary shares | 54,905,822 | 99.94% | 32,175 | 0.06% | 54,937,997 | Nil |
| 9 | Special resolution to authorise the directors to dis-apply statutory pre-emption rights pursuant to section 570 of the Companies Act 2006 | 53,670,136 | 99.92% | 44,461 | 0.08% | 54,937,997 | 1,223,400 |
| 10 | Special resolution to authorise the directors to make market purchase of its ordinary shares | 52,510,452 | 99.99% | 577 | 0.01% | 54,937,997 | 2,426,968 |
| 1 1 | Ordinary resolution to approve The Diaceutics Unapproved Share Option Plan | 51,312,153 | 93.40% | 3,625,844 | 6.60% | 54,937,997 | Nil |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.